4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-018441
Director acquired 2,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kung Winston Director | 2024-06-26 | Grant or award | +2,500 | 2,500 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kung Winston Director | 2024-06-26 | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | D: show line 2 in the form |
Loading xslF345X05/form4-06282024_040641.xml…